Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Gholamreza Olad

1PUBLICATIONS

9CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Aug 27, 2022

Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial.

Jafar Salimian, Ali Ahmadi, Jafar Amani

Pageof 1

Frequent Collaborators

1 joint publications

Jafar Salimian

1 joint publications

Ali Ahmadi

1 joint publications

Jafar Amani

1 joint publications

Raheleh Halabian

1 joint publications

Ali Saffaei

1 joint publications

Masoud Arabfard

1 joint publications

Mojtaba Nasiri

1 joint publications

Hassan Abolghasemi

1 joint publications

Gholamhossein Alishiri

Frequent Collaborators

1 joint publications

Jafar Salimian

1 joint publications

Ali Ahmadi

1 joint publications

Jafar Amani

1 joint publications

Raheleh Halabian

Top Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Published on : Sep 01, 2023

See more related videos

Top Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Published on : Sep 01, 2023

See more related videos